Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma
Official title: Fractional Co2 Laser vs Dermabrasion 5-Flurouracil Delivery in Acquired Leukoderma: A Comparative Study
Status: Opening soon
Description:
This randomized controlled prospective single-blinded comparative clinical study aims to compare the efficacy and safety of fractional carbon dioxide (CO2) laser therapy versus mechanical dermabrasion, both combined with topical 5-fluorouracil, in the treatment of acquired non-vitiligo leukoderma. The study will evaluate repigmentation, clinical improvement, patient satisfaction, and treatment-related adverse effects.
What is being studied: device — Fractional CO2 Laser; procedure — Dermabrasion; drug — 5-Fluorouracil.
Who can take part: ages 18 Years to 75 Years, 16 participants planned.
Enrollment status: Opening soon. The study started 26 August 2026 and is expected to finish 26 August 2027.
Contact: Walaa Ashraf Sayed.
Source: ClinicalTrials.gov, NCT07837908 (https://clinicaltrials.gov/study/NCT07837908).
Start date: August 26, 2026
Completion date: August 26, 2027
Organizer: Al-Azhar University
Contact: Walaa Ashraf Sayed
Tel.: MBBS
Email: walaaashraf464@yahoo.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- How can I cure vitiligo?
Right now, there is no universal "cure," but we have entered a new era of treatment. Today, managing vitiligo isn’t just about "hiding" it; it’s about sophisticated science that...
- What are the best predictors for therapy response in vitiligo?
A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...
- Vitiligo trials for kids: basics for the parents
Pediatric vitiligo trials · The basics Two parallel studies are evaluating investigational use of ruxolitinib cream in young children — researchers are still finding out how wel...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.